1. Home
  2. DFH vs PRCT Comparison

DFH vs PRCT Comparison

Compare DFH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

HOLD

Current Price

$11.28

Market Cap

1.4B

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$17.30

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFH
PRCT
Founded
2008
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DFH
PRCT
Price
$11.28
$17.30
Analyst Decision
Hold
Buy
Analyst Count
2
11
Target Price
$26.00
★ $35.44
AVG Volume (30 Days)
891.1K
★ 1.2M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.71
EPS
★ 0.37
N/A
Revenue
★ $4,322,848,000.00
$308,054,000.00
Revenue This Year
$0.81
$31.34
Revenue Next Year
$7.82
$24.52
P/E Ratio
$30.47
★ N/A
Revenue Growth
N/A
★ 37.22
52 Week Low
$10.87
$16.67
52 Week High
$27.20
$38.11

Technical Indicators

Market Signals
Indicator
DFH
PRCT
Relative Strength Index (RSI) 36.33 33.27
Support Level N/A $16.89
Resistance Level $16.47 $29.27
Average True Range (ATR) 0.69 0.94
MACD -0.08 -0.35
Stochastic Oscillator 12.05 4.26

Price Performance

Historical Comparison
DFH
PRCT

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc designs, builds and sells homes in markets throughout the United States. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the maximum of its revenue from the Midwest segment.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: